ALC

Alcon Stock Price

63.19
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
63.19
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Alcon Inc ALC NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 63.19 19:00:00
Open Price Low Price High Price Close Price Previous Close
63.19
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 63.19 USD

Alcon Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 30.91B 489.20M 489.20M $ 7.51B $ -790.59M -1.34 -43.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Alcon News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week63.3764.9662.7763.89988,716-0.18-0.28%
1 Month61.9568.1161.4864.161,217,6791.242.0%
3 Months56.6668.1154.9860.521,163,7946.5311.52%
6 Months63.8868.1154.5159.821,207,267-0.69-1.08%
1 Year55.5768.1139.3757.321,288,5407.6213.71%
3 Years58.24568.1139.3757.751,299,6894.958.49%
5 Years58.24568.1139.3757.751,299,6894.958.49%

Alcon Description

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with 41% of revenue in the U.S. market, and the firm has a strong presence in the European Union and Japan.


Your Recent History
NYSE
ALC
Alcon
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.